Definition
Widespread, uncontrolled clot formation and bleeding due to loss of coagulation regulation.
Pathophysiology of DIC
->Widespread, uncontrolled clot formation throughout microvasculature.
Triggered by factors like:
* Bacterial endotoxins (e.g., LPS)
* Tissue factor from monocytes or placenta
* Endothelial glycocalyx damage
Wide spread coagulation results in depletion of procoagulant factors –> consumptive coagulopathy
BET by Mom leads to wide spread coagulation and as a result consumption coagulopathy
B- Bacterial endotoxin
E- Endothelial glycocalyx damage
T- Tissue factor release from monocytes or placenta
Life threatening consequences of DIC
Life-Threatening Consequences of DIC
1. Disseminated microvascular thrombosis:
- tissue hypoperfusion and damage
2. Macrovascular thrombosis:
-May result in DVT or PE
3. Hemorrhage:
* Due to depletion of clotting factors (consumptive coagulopathy)
Types of DIC
=> Acute DIC:
* Sudden trigger (e.g., sepsis)
* Rapid depletion of clotting proteins
* Prominent bleeding/thrombotic features
* Common in ICU/critical care
=> Chronic DIC:
* Ongoing low-level activation (e.g., adenocarcinomas)
* Slower consumption of coagulation factors
* Often clinically compensated, mild lab changes
Clinical conditions causing DIC
Trauma, Transfusion, Malignancy, Meningococcemia, Sepsi
Mnemonic- TTOMMS
Pts with solid tumors- greater risk of thrombosis than haemorrhage
Pts with haem malignancy eg- AML- greater risk of Bleeding because of hyperfibrinolytic state
Causes in the young
MSK(musculoskeletal)
Causes of DIC in young females
What are some clinical manifestations of DIC
=>May be asymptomatic or show signs of bleeding and/or thrombosis.
-> Microvascular thrombosis → organ failure:
* Renal failure.
* ARDS.
* Neurological: delirium, coma, seizure.
* Adrenal insufficiency (Waterhouse-Friedrichsen syndrome).
* Skin: Purpura fulminans (severe form requiring aggressive management).
-> Macrovascular thrombosis:
* Deep vein thrombosis (DVT).
* Pulmonary embolism (PE).
-> Bleeding:
* Petechiae, purpura.
* Oozing from catheters or mucosa.
* GI or intracranial hemorrhage (less common, but serious).
DIC Screening Lab Panel
D/Dx
=>DIC- is a clinical diagnosis with 3 major components:
*Underlying disorder known to cause DIC
*Constellation of characterstic lab anomalies
*Exclusion of alternative explanations.
D/Dx
Cirrhosis
=>1. Cirrhosis:
* Risk factor for DIC.
* Liver disease: reduced synthesis of clotting factors, fibrinolytic proteins.
* Balance easily disrupted by insults.
* D Dimer: usually elevated in both DIC and advanced liver disease.
Factor VIII: produced by endothelium; normal in cirrhosis, reduced in DIC.
D/D of coagulopathy:
Dimple Hai Senior Critical Care Trainee
DIC, HITS, Cirrhosis, CAPS, SIC, TTP, HUS
HIT
2. HIT
(Heparin-Induced Thrombocytopenia)
* Exposure to heparin essential.
* ELISA & serologic assay helps in diagnosis.
* Fibrinogen:
- Normal in HIT.
- Decreased in DIC.
3. Primary Thrombotic Microangiopathies (TTP, HUS)
=>3. Primary Thrombotic Microangiopathies (TTP, HUS)
* Platelets < 30k suggests TTP > DIC.
* Schistocytes seen in both but TTP,HUS»DIC
* TTP: ADAMTS13 deficiency or autoantibodies.
* INR/PTT/Fibrinogen: typically normal in TTP because:
Coagulation factors not consumed in TTP(coagulation sys is not activated- clots composed of platelets only)
CAPS
=>4. CAPS (Catastrophic Antiphospholipid Syndrome)
* Can mimic DIC in ~25% of cases.
* Associated with SLE, APLA/pregnancy loss
* Skin Manifestations-eg- cutaneous necrosis
* Triggers: infection, anticoag withdrawal, surgery.
SIC
5. Sepsis induced thrombocytopenia and coagulopathy-(SIC)
-Fibrinolysis suppressed–>impaired breakdown of microthrombi
-Fibrinogen levels- normal or high
DIC INVx
1) D-dimer
⸻
2) Thrombocytopenia
⸻
3) INR and PTT
* Prolonged INR/PTT supports DIC but may be normal in >50% of cases.
* These tests measure clotting factor levels, not anticoagulant factor depletion.
⸻
4) Fibrinogen
* Least sensitive marker (only ~25% sensitivity).
* Low fibrinogen supports DIC, but levels may be normal or elevated in sepsis.
* Falling fibrinogen over time is more suggestive.
* Markedly low levels may suggest hyperfibrinolysis.
⸻
5) Antithrombin III
* Consumed in DIC → reduced levels.
* May explain heparin resistance in DIC.
* Can indicate early (non-overt) DIC.
=>Other causes of low AT III:
* ECMO, dialysis, IABP
* Heparin therapy
* Cirrhosis (not produced)
* Nephrotic syndrome(excess clearence)
⸻
6) Microangiopathic Hemolytic Anemia (MAHA)
* Caused by microthrombi in capillaries.
* Leads to intravascular hemolysis and schistocytes on blood film.
⸻
7) Thromboelastography (TEG) in DIC
* TEG provides a whole-blood overview of coagulation.
* May reveal hypercoagulability early
* Later stages of DIC may show hypocoagulability.
* Most common TEG abnormality in DIC: reduced maximal amplitude (MA).
Heparin ⬇️es ATIII leves -mech- binds to ATIII and then is cleared rapidly- apparent deficiency, not actual.
Treatment
=>Management of DIC
1. Treat the underlying disorder
* Sepsis: antibiotics + supportive care.
* APL (acute promyelocytic leukemia): ATRA.
* Purpura fulminans: aggressive supportive treatment.
2. Platelet transfusion ->Generally avoided unless: * Platelets <10,000/µL. * Planned procedure or high bleeding risk. * Ongoing active bleeding. * Aim for platelets >50,000/µL in high-risk settings. 3. Fibrinogen supplementation * If active bleeding: aim for fibrinogen 1.5–2 g/L. 4. Clotting factor replacement * Based on TEG results, especially if bleeding is ongoing. 5. Vitamin K administration * Can be given if deficiency suspected. 6.** Heparin * Generally not beneficial in DIC due to already low antithrombin (AT) levels.** 7. **Antithrombin III (ATIII) replacement** * May help in septic shock or DIC with low AT levels. 8. Protein C concentrates * Considered for patients with meningococcemia or purpura fulminans–associated DIC.
D/Dx
Cirrhosis
HITTS
TMAs (thrombotic microangiopathies)
CAPS
Sepsis
1. Cirrhosis:
* Risk factor for DIC. * Liver disease: reduced synthesis of clotting factors, fibrinolytic proteins. * Balance easily disrupted by insults. * DDimer: usually elevated in both DIC and advanced liver disease. **Factor VIII:** produced by endothelium; normal in cirrhosis, reduced in DIC.
(Heparin-Induced Thrombocytopenia)
* Exposure to heparin essential.
* ELISA & serologic assay helps in diagnosis.
* Fibrinogen:
- Normal in HIT.
- Decreased in DIC.
Primary Thrombotic Microangiopathies
* Platelets < 30k suggests TTP > DIC.
* Schistocytes seen in both but TTP,HUS»DIC
* TTP: ADAMTS13 deficiency or autoantibodies.
* INR/PTT/Fibrinog
en: typically normal in TTP.
**Coagulation factors not consumed in TTP(coagulation sys is not activated- clots composed of platelets only)**. * TTP/HUS: LDH very high(sec to tissue ischemia). * Key distinguishing features: thrombocytopenia, hemolysis, schistocytes, neuro symptoms.
(Catastrophic Antiphospholipid Syndrome)
* Can mimic DIC in ~25% of cases.
* Associated with SLE, APLA/pregnancy loss
.Skin Manifestations-eg- cutaneous necrosis
* Triggers: infection, anticoag withdrawal, surgery.
Sepsis induced thrombocytopenia and coagulopathy
-Fibrinolysis suppressed–>impaired breakdown of microthrombi
-Fibrinogen levels- normal or high
***DIC- is a clinical diagnosis with 3 major components:
*Underlying disorder known to cause DIC
*Constellation of characterstic lab anomalies
*Exclusion of alternative explanations.